Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-23

Clinical Trial Update: Vitamin D Supplementation and the Immune Response [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Vitamin D supplementation on immune response has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: D Vitamin Deficiency Patients | Phase 2 | Status: TERMINATED